+Compare
DERM
Stock ticker: NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
53.49M

DERM Journey Medical Corp Forecast, Technical & Fundamental Analysis

a manufacturer of pharmaceutical products

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I.Advisor
a Summary for DERM with price predictions
08:00 PM EDT Sep 21, 2023

DERM's Stochastic Oscillator reaching overbought zone

The Stochastic Oscillator for DERM moved into overbought territory on September 22, 2023. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for DERM moved out of overbought territory on September 12, 2023. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 16 similar instances where the indicator moved out of overbought territory. In of the 16 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DERM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

DERM broke above its upper Bollinger Band on September 06, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 31, 2023. You may want to consider a long position or call options on DERM as a result. In of 61 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for DERM just turned positive on September 06, 2023. Looking at past instances where DERM's MACD turned positive, the stock continued to rise in of 28 cases over the following month. The odds of a continued upward trend are .

DERM moved above its 50-day moving average on August 23, 2023 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where DERM advanced for three days, in of 150 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 83 cases where DERM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. DERM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: DERM's P/B Ratio (10000.000) is very high in comparison to the industry average of (85.163). P/E Ratio (0.000) is within average values for comparable stocks, (58.521). DERM's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (3.385). DERM has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.027). P/S Ratio (0.870) is also within normal values, averaging (61.283).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DERM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are ZOETIS (NYSE:ZTS), Teva Pharmaceutical Industries Limited (NYSE:TEVA), Elanco Animal Health (NYSE:ELAN), Intra-Cellular Therapies (NASDAQ:ITCI), Bausch Health Companies (NYSE:BHC), Tilray Brands (NASDAQ:TLRY), Avadel Pharmaceuticals plc (NASDAQ:AVDL), Canopy Growth Corp (NASDAQ:CGC), Aurora Cannabis (NASDAQ:ACB), Journey Medical Corp (NASDAQ:DERM).

Industry description

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

Market Cap

The average market capitalization across the Pharmaceuticals: Other Industry is 2.57B. The market cap for tickers in the group ranges from 246 to 81.33B. ZTS holds the highest valuation in this group at 81.33B. The lowest valued company is PEMTF at 246.

High and low price notable news

The average weekly price growth across all stocks in the Pharmaceuticals: Other Industry was 3%. For the same Industry, the average monthly price growth was 17%, and the average quarterly price growth was 10%. CHHE experienced the highest price growth at 1,900%, while INNPF experienced the biggest fall at -99%.

Volume

The average weekly volume growth across all stocks in the Pharmaceuticals: Other Industry was -55%. For the same stocks of the Industry, the average monthly volume growth was 87% and the average quarterly volume growth was 73%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 54
P/E Growth Rating: 71
Price Growth Rating: 58
SMR Rating: 85
Profit Risk Rating: 92
Seasonality Score: -11 (-100 ... +100)
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
A.I. Advisor
published Earnings

DERM is expected to report earnings to rise 200.00% to -137 cents per share on March 23

Journey Medical Corp DERM Stock Earnings Reports
Q4'19
Est.
$-1.38
Q2'23
Missed
by $0.15
Q1'23
Missed
by $0.04
Q4'22
Missed
by $0.13
Q3'22
Beat
by $0.11
The last earnings report on August 07 showed earnings per share of -46 cents, missing the estimate of -31 cents. With 101.40K shares outstanding, the current market capitalization sits at 53.49M.
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Biotechnology
Address
9237 E Via de Ventura Boulevard
Phone
+1 480 434-6670
Employees
80
Web
https://www.journeymedicalcorp.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MOMO7.080.13
+1.87%
Hello Group
NVDA416.105.93
+1.45%
NVIDIA Corp
GCMG7.67-0.04
-0.52%
GCM Grosvenor
EPOW1.99-0.02
-1.00%
Sunrise New Energy Co Ltd
ENLC12.30-0.13
-1.05%
Enlink Midstream LLC

DERM and

Correlation & Price change

A.I.dvisor tells us that DERM and CHRS have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DERM and CHRS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DERM
1D Price
Change %
DERM100%
-0.67%
CHRS - DERM
27%
Poorly correlated
+7.73%
FNCH - DERM
26%
Poorly correlated
-3.27%
VXRT - DERM
24%
Poorly correlated
+0.30%
DRMA - DERM
22%
Poorly correlated
+0.46%
ITRM - DERM
22%
Poorly correlated
-0.37%
More

Groups containing DERM

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DERM
1D Price
Change %
DERM100%
-0.67%
pharmaceuticals
(undefined stocks)
13%
Poorly correlated
-0.53%
drugs
(undefined stocks)
12%
Poorly correlated
-0.89%
biotechnology
(undefined stocks)
10%
Poorly correlated
-0.81%
Pharmaceuticals
(undefined stocks)
0%
Poorly correlated
-0.04%
Pharmaceuticals: Other
(undefined stocks)
0%
Poorly correlated
-0.03%